secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001654954-25-007011
Event type: earnings
Sentiment:  positive
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv reports Q2 net income of $0.1M, reversing prior-year loss
-------------------------------------------------------------------------

- Q2 revenue $2.4M (vs $2.3M YoY); six-month revenue $4.9M (vs $4.8M YoY).
- Net income for Q2 and first half $0.1M each, up $0.3M and $0.6M vs prior-year losses.
- CEO cites focus on high-margin projects as driver of improved profitability.
- No guidance provided; OTCQB ticker PBSV remains unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425007011/0001654954-25-007011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425007011/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-007011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer